R/R AML

Clinical trials for R/R AML explained in plain language.

Never miss a new study

Get alerted when new R/R AML trials appear

Sign up with your email to follow new studies for R/R AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Engineered immune cells take on stubborn leukemia

Disease control Not yet recruiting

This early-phase study tests a new type of cell therapy called CAR-ITNK for people with relapsed or refractory acute myeloid leukemia (AML), a blood cancer that has not responded to standard treatments. The therapy uses specially engineered immune cells that target two proteins, …

Matched conditions: R/R AML

Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

R/R AML

Get alerted when new R/R AML trials appear

Engineered immune cells take on stubborn leukemia